- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03711357
Effect of 980nm Diode Laser on Postoperative Pain and Root Canal Disinfection in Endodontic Retreatment Cases
October 16, 2018 updated by: Eman Nabil El-Ezaby, Cairo University
Evaluation of the Effect of 980nm Diode Laser Intracanal Irradiation on Postoperative Pain and Root Canal Disinfection in Endodontic Retreatment Cases With Chronic Periapical Lesions
A randomized clinical trial that evaluates the effect of using 980nm diode laser intracanal irradiation on postoperative pain and root canal disinfection in endodontic retreatment cases with chronic periapical lesions
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The endodontic retreatment procedures will be carried out for the participants, then 980nm Diode laser will be used to disinfect root canals.
The researcher will then take microbiological samples of the root canals, to determine count and type of microorganisms in root canals.
The subject will be asked to determine his level of pain at 7 days after endodontic retreatment procedures in a visual analogue scale (VAS), and to determine number of analgesic tablets needed to relieve his pain in the given charts.
The subject will then return to the clinic 7 days later to bring back his charts.
The researcher then will take another microbiological sample of the root canals, and complete the endodontic retreatment procedures.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Endodontic retreatment cases of single rooted teeth with chronic periapical lesions; with periapical radiolucency of less than 1 cm diameter will be selected.
- Teeth with straight root canals.
- Subjects aged between 18-50 years of age.
- No contributory medical history.
- No previous administration of analgesics and / or antibiotics within the previous 2 weeks.
Exclusion Criteria:
- Retreatment cases with complications such as separated instruments, perforations, ledges, resorption, transportation, calcifications, immature apices and over fillings.
- Teeth with curved roots.
- Swelling or sinus tract.
- Mutilated teeth that interfere with proper isolation and seal between visits.
- Subjects with generalized periodontitis, or if the tooth has probing depth of more than 3 mm.
- Subjects with uncontrolled diabetes or debilitating diseases.
- Pregnant or nursing females.
- Systemic disorders that necessitate antibiotic prophylaxis or prevent the use of Ibuprofen.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: laser
980 nm diode laser (maximum output of 3 watts and coupled with a fiber optic tip of 200 µm diameter) will be used for four irradiations, of 5 seconds each, after chemo-mechanical preparation procedures.
|
980 nm high power diode laser device.
|
|
Placebo Comparator: Placebo
After chemo-mechanical preparation procedures, the diode laser fiber optic tip will be inserted inside the root canals but not activated.
|
the diode laser fiber optic tip will be inserted in root canals, but will not be activated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative pain, measured using Visual analogue scale (VAS)
Time Frame: 7 days after root canal re-treatment procedures
|
Visual analogue scale (VAS) will be used for to record severity of pain.
It is a (0-10) scale.
Criteria to determine the severity of postoperative pain will be as follows: (0: no pain), (1-3: mild pain), (4-6: moderate pain), (7-10: severe pain).
|
7 days after root canal re-treatment procedures
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Root canal disinfection
Time Frame: Four samples will be taken; first, second and third samples will be taken at first visit of endodontic retreatment procedures. while, the fourth sample will be taken in the second visit (7 days later).
|
Number of microorganisms found in root canals will be determined using "Bacterial culture";"Initial sample", 'Pre-lasing sample, "Post-lasing".
and "Recolonization sample", in the "Laser group" and "Placebo group".
|
Four samples will be taken; first, second and third samples will be taken at first visit of endodontic retreatment procedures. while, the fourth sample will be taken in the second visit (7 days later).
|
|
number of analgesic tablets
Time Frame: At day 7 after endodontic retreatment procedures
|
the participant will determine the number of analgesic tablets needed to relieve his pain after endodontic retreatment procedures.
|
At day 7 after endodontic retreatment procedures
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 1, 2018
Primary Completion (Anticipated)
May 1, 2020
Study Completion (Anticipated)
June 1, 2020
Study Registration Dates
First Submitted
October 13, 2018
First Submitted That Met QC Criteria
October 16, 2018
First Posted (Actual)
October 18, 2018
Study Record Updates
Last Update Posted (Actual)
October 18, 2018
Last Update Submitted That Met QC Criteria
October 16, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Eman Elezaby
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to make the participants data available to other researchers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.